Genetic testing and the clinical laboratory improvement amendments of 1988: Present and future

Clinical Chemistry

Volumn 45, Issue 5, 1999, Pages 739-745

  Schwartz, Morton K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC VALUE; FUTUROLOGY; GENETIC DISORDER; LABORATORY TEST; LAW; REVIEW;

EID: 0032898602     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.5.739     Document Type: Review

References (8)

1. 1. Public Law 100-578: Clinical Laboratory Improvement Amendments of 1988 October 31, 1988. Fed Regist 1992;57:7002-3.
2. 2. Centers for Disease Control and Prevention regulations for implementing Clinical Laboratory Improvement Amendments of 1988: summary. MMWR 1992;41(RR-2):1-17.
3. 3. Health Care Financing Administration, US Department of Health and Human Services, Laboratory Requirements. Code of Federal Regulations, Part 493, Title 42, 1997:798-923.
4. 4. Green ED, Cox DR, Myers RM. In: Vogelstein B, Kinzler KW, eds. The Human Genome Project and its impact on the study of human disease in the genetic bases of human cancer. New York: McGrawHill, 1998:129-59.
5. 5. McGovern M. Ensuring accurate genetic testing [Editorial]. Clin Chem 1998;44:1146-8.
6. 6. Roundtable. Ethical dilemmas in genetic testing. Lab Med 1995; 28:311-5.
7. 7. Holtzman NA, Watson MS, eds. Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. Bethesda, MD: National Institutes of Health, 1997:175pp.
8. 8. Translating advances in human genetics into public health action: a strategic plan. Atlanta, GA: Centers for Disease Control and Prevention, 1997:13pp.